# Intuitive Surgical, Inc. (ISRG) FY2025 Annual Balance Sheet

- Company: Intuitive Surgical, Inc. (ISRG)
- Period: As of 2025-12-31
- Filing: FY2025 10-K, filed 2026-02-03, accession number 0001035267-26-000010
- Page: https://plicit.ai/financials/isrg/fy2025-annual-balance-sheet
- Chart image: https://plicit.ai/charts/isrg-fy2025-annual-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2025-12-31. The chart shows assets, liabilities and equity at that date.

- **Assets**: 20,458,700,000 US dollars
- **Current assets**: 9,779,500,000 US dollars
- **Non-current assets**: 10,679,200,000 US dollars
- **Liabilities**: 2,517,000,000 US dollars
- **Current liabilities**: 2,006,200,000 US dollars
- **Non-current liabilities**: 510,800,000 US dollars
- **Equity**: 17,941,700,000 US dollars
- **Noncontrolling interest**: 117,700,000 US dollars. Included in consolidated equity; this amount is not added again.
- **Cash and cash equivalents**: 3,368,000,000 US dollars
- **Short-term investments**: 2,566,900,000 US dollars
- **Inventory**: 1,840,000,000 US dollars
- **Accounts receivable, net of allowances of $29.9 and $30.7 as of December 31, 2025, and 2024, respectively**: 1,527,300,000 US dollars
- **Prepaids and other current assets**: 477,300,000 US dollars
- **Property, plant, and equipment, net**: 5,342,400,000 US dollars
- **Long-term investments**: 3,099,200,000 US dollars
- **Deferred tax assets**: 1,018,600,000 US dollars
- **Intangible and other assets, net**: 848,700,000 US dollars
- **Goodwill**: 370,300,000 US dollars
- **Accrued compensation and employee benefits**: 648,400,000 US dollars
- **Other accrued liabilities**: 596,000,000 US dollars
- **Deferred revenue**: 506,700,000 US dollars
- **Accounts payable**: 255,100,000 US dollars
- **Other long-term liabilities**: 510,800,000 US dollars
- **Additional paid-in capital**: 10,768,500,000 US dollars
- **Retained earnings**: 7,011,800,000 US dollars
- **Accumulated other comprehensive income (loss)**: 43,300,000 US dollars
- **Common stock, 600.0 shares authorized, $0.001 par value, 355.1 shares and 356.6 shares issued and outstanding as of December 31, 2025, and 2024, respectively**: 400,000 US dollars
- **Preferred stock, 2.5 shares authorized, $0.001 par value, issuable in series; zero shares issued and outstanding as of December 31, 2025, and 2024**: 0 US dollars
- **Noncontrolling interest in joint venture**: 117,700,000 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.